Reversion of CTL escape-variant immunodeficiency viruses in vivo.
D016915:AIDS Vaccines; D000595:Amino Acid Sequence; D000818:Animals; D019143:Evolution, Molecular; D005805:Genes, MHC Class I; D006680:HLA Antigens / Q000378:metabolism; D006801:Humans; D016056:Immunodominant Epitopes / Q000235:genetics* / Q000276:immunology; D008253:Macaca mulatta; D008969:Molecular Sequence Data; D009154:Mutation; D016415:Sequence Alignment; D016097:Simian Acquired Immunodeficiency Syndrome / Q000276:immunology / Q000821:virology*; D015302:Simian Immunodeficiency Virus / Q000235:genetics / Q000276:immunology / Q000472:pathogenicity / Q000502:physiology*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000378:metabolism; D014779:Virus Replication / Q000502:physiology
D016915:AIDS Vaccines; D006680:HLA Antigens; D016056:Immunodominant Epitopes